MindMed discovers and develops psychedelics inspired medicines

Gilgamesh is developing the next generation of central nervous system drugs derived from psychedelics

Diamond Therapeutics develops psilocybin based medicines while mitigating side effects

Myco Systemics' mission is to provide systemic scalable myco-cultivation infrastructure to enable producers to meet the demands of the exploding global mushroom market

Tactogen is a public benefit cooperation whose goal is to make transformative medicines safer, more effective, and more accessible

Mindleap's integration coaches help you to understand and embody the most important parts of your Psychedelic trip, allowing you to create lasting personal transformation.

ATAI is committed to developing more effective and potentially disease-modifying mental health treatments by researching both psychedelic and non-psychedelic compounds.

Universal Ibogaine's mission is to bring proven Ibogaine based clinical treatment protocol to the world and help solve the international opioid crisis

Harnessing the powerful medicinal and nutritional benefits of mushrooms. The world needs better approaches to mental health and overall well-being. GoodCap is developing effective mushroom-based treatments that open new pathways to a healthier future.

Gwella's focus is on developing transformative consumer brands, products and technologies aimed at elevating people's health and wellbeing.

Lucid News provides informed, honest and transparent journalism that covers the growing integration of psychedelics into society and their broad implications for human wellness.

Orthogonal's mission is to give people access to nature’s most effective health solutions while setting the standard of a new “Farma”: Food as Medicine.

.

A digital media company covering psychedelics and all they intersect with, from healthcare disparities to the climate crisis

.

A life sciences company whose mission is to treat traumatic brain injury and other mental health ailments using psilocybin and other natural therapies.